litlas
Log inCreate account

John Bryant

Active 1968–2025

67
Papers
39,989
Citations
49
h-index
60
i10-index

Citations

Citations per year for John Bryant1969: 3 citations1970: 2 citations1974: 1 citations1977: 3 citations1978: 1 citations1979: 1 citations1980: 1 citations1981: 2 citations1983: 2 citations1984: 1 citations1986: 3 citations1988: 4 citations1990: 1 citations1991: 3 citations1992: 2 citations1993: 9 citations1994: 3 citations1995: 16 citations1996: 11 citations1997: 17 citations1998: 51 citations1999: 55 citations2000: 84 citations2001: 134 citations2002: 114 citations2003: 175 citations2004: 192 citations2005: 287 citations2006: 361 citations2007: 427 citations2008: 433 citations2009: 443 citations2010: 411 citations2011: 368 citations2012: 316 citations2013: 340 citations2014: 262 citations2015: 256 citations2016: 216 citations2017: 184 citations2018: 203 citations2019: 649 citations2020: 651 citations2021: 548 citations2022: 421 citations2023: 283 citations2024: 449 citations2025: 170 citations2026: 8 citations1971–1973: no citations, so these years are not shown1975–1976: no citations, so these years are not shown1982: no citations, so this year is not shown1985: no citations, so this year is not shown1987: no citations, so this year is not shown1989: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,816 citing papers, 33.2% of this breakdownUnited Kingdom: 859 citing papers, 7.5% of this breakdownItaly: 607 citing papers, 5.3% of this breakdownChina: 584 citing papers, 5.1% of this breakdownGermany: 567 citing papers, 4.9% of this breakdownCanada: 549 citing papers, 4.8% of this breakdownFrance: 387 citing papers, 3.4% of this breakdownNetherlands: 376 citing papers, 3.3% of this breakdownSwitzerland: 315 citing papers, 2.7% of this breakdownSpain: 266 citing papers, 2.3% of this breakdownAustralia: 257 citing papers, 2.2% of this breakdownBelgium: 256 citing papers, 2.2% of this breakdown
0%33.2%Other 23.1%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology46.6%
  • Medicine41%
  • Immunology and Microbiology2.7%
  • Computer Science2.3%
  • Economics, Econometrics and Finance1.4%
  • Engineering1%
  • Other5%

Topics

  • Breast Cancer Treatment Studies14.8%
  • HER2/EGFR in Cancer Research6.3%
  • Breast Lesions and Carcinomas5.9%
  • Breast Implant and Reconstruction3.7%
  • Cancer Genomics and Diagnostics2.5%
  • Estrogen and related hormone effects2.4%
  • Other64.4%

Coauthors

All papers

Open in search
  1. A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer

    Authors: Soonmyung Paik, Steven Shak, Gong Tang, Chungyeul Kim, Joffre Baker, Maureen Cronin, Frederick L. Baehner, Michael G. Walker, Drew Watson, Taesung Park, W. Douglas B. Hiller, Edwin R. Fisher, D. Lawrence Wickerham, John Bryant, Norman Wolmark - New England Journal of Medicine 2004 cited by 6,358

  2. Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

    Authors: Bernard Asselain, William E. Barlow, John M.S. Bartlett, Jonas Bergh, Elizabeth Bergsten-Nordström, Judith M. Bliss, Francesco Boccardo, Clare Boddington, Jan Bogaerts, Gianni Bonadonna, Rosie Bradley, Étienne Brain, Jeremy Braybrooke, Philippe Broët, John Bryant, Julie Ann Burrett, David Cameron, Mike Clarke, Alan S. Coates, Robert L. Coleman, Raoul Charles Coombes, Candace R. Correa, Joe Costantino, Jack Cuzick, David N. Danforth, Nancy E. Davidson, Christina Davies, Lucy Davies, Angelo Di Leo, David Dodwell, Mitch Dowsett, Frances Duane, Vaughan Evans, Marianne Ewertz, Bernard Fisher, John Forbes, Leslie G. Ford, J.-C. Gazet, Richard D. Gelber, Lucy Gettins, Luca Gianni, Michael Gnant, Jon Godwin, Aron Goldhirsch, Pamela J. Goodwin, Richard Gray, Daniel F. Hayes, Catherine Hill, James N. Ingle, Reshma Jagsi, R. Jakesz, Sam James, Wolfgang Janni, Hui Liu, Zulian Liu, Caroline Lohrisch, Sibylle Loibl, Liz MacKinnon, Andreas Makris, Eleftherios P. Mamounas, Gurdeep Mannu, Miguel Martín, S. Mathoulin, L. Mauriac, Paul McGale, Theresa McHugh, Philip Morris, Hirofumi Mukai, Larry Norton, Yasuo Ohashi, Ivo A. Olivotto, Soon Young Paik, Hongchao Pan, Richárd Pető, Martine Piccart, Lori J. Pierce, Philip Poortmans, Trevor J. Powles, K.I. Pritchard, Joseph Ragaz, Vinod Raina, Peter M. Ravdin, Simon Read, Meredith M. Regan, J.F.R. Robertson, Emiel J. Rutgers, Suzy Scholl, Dennis J. Slamon, Lidija Sölkner, Joseph A. Sparano, Seth M. Steinberg, Rosemary Sutcliffe, Sandra M. Swain, Carolyn Taylor, Andrew Tutt, Pinuccia Valagussa, Cornelis J.�H. van de Velde, Jos A. van der Hage, Giuseppe Viale, Gϋnter von Minckwitz and 10 more - The Lancet Oncology 2017 cited by 1,133

  3. Trastuzumab plus Adjuvant Chemotherapy for Operable HER2-Positive Breast Cancer

    Authors: Edward H. Romond, Edith A. Perez, John Bryant, Vera J. Suman, Charles E. Geyer, Nancy E. Davidson, Elizabeth Tan-Chiu, Silvana Martino, Soonmyung Paik, Peter A. Kaufman, Sandra M. Swain, Thomas M. Pisansky, Louis Fehrenbacher, Leila A. Kutteh, Victor G. Vogel, Daniel W. Visscher, Greg Yothers, Robert B. Jenkins, Ann Brown, Shaker R. Dakhil, Eleftherios P. Mamounas, Wilma L. Lingle, Pamela Klein, James N. Ingle, Norman Wolmark - New England Journal of Medicine 2005 cited by 5,353

  4. Twenty-Year Follow-up of a Randomized Trial Comparing Total Mastectomy, Lumpectomy, and Lumpectomy plus Irradiation for the Treatment of Invasive Breast Cancer

    Authors: Bernard Fisher, Stewart Anderson, John Bryant, Richard G. Margolese, Melvin Deutsch, Edwin R. Fisher, Jong‐Hyeon Jeong, Norman Wolmark - New England Journal of Medicine 2002 cited by 6,228

  5. Survival in Patients With Brain Metastases: Summary Report on the Updated Diagnosis-Specific Graded Prognostic Assessment and Definition of the Eligibility Quotient

    Authors: Paul W. Sperduto, Shane Mesko, Jing Li, Daniel Cagney, Ayal A. Aizer, Nancy U. Lin, Eric Nesbit, Tim J. Kruser, Jason W. Chan, Steve Braunstein, Jessica Lee, John P. Kirkpatrick, Will Breen, Paul D. Brown, Diana D. Shi, Helen A. Shih, Hany Soliman, Arjun Sahgal, Ryan Shanley, William Sperduto, Emil Lou, Ashlyn S. Everett, Drexell H. Boggs, Laura Masucci, David Roberge, Jill Remick, Kristin A. Plichta, John M. Buatti, Supriya Jain, Laurie E. Gaspar, Cheng–Chia Wu, Tony J. C. Wang, John Bryant, Michael D. Chuong, Yi An, Veronica Chiang, Toshimichi Nakano, Hidefumi Aoyama, Minesh P. Mehta - Journal of Clinical Oncology 2020 cited by 467

  6. Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer

    Authors: Soonmyung Paik, Gong Tang, Steven Shak, Chungyeul Kim, Joffre Baker, Wanseop Kim, Maureen Cronin, Frederick L. Baehner, Drew Watson, John Bryant, Joseph P. Costantino, Charles E. Geyer, D. Lawrence Wickerham, Norman Wolmark - Journal of Clinical Oncology 2006 cited by 2,577

  7. Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial

    Authors: Frank A. Vicini, Reena S. Cecchini, Julia White, Douglas W. Arthur, Thomas B. Julian, Rachel Rabinovitch, Robert R. Kuske, Patricia A. Ganz, David S. Parda, Michael F. Scheier, Kathryn Winter, Soonmyung Paik, Henry M. Kuerer, Laura A. Vallow, Lori J. Pierce, Eleftherios P. Mamounas, Beryl McCormick, Joseph P. Costantino, Harry D. Bear, Isabelle Germain, G.S. Gustafson, Linda Grossheim, Ivy A. Petersen, Richard Hudes, Walter J. Curran, John Bryant, Norman Wolmark - The Lancet 2019 cited by 475

  8. Twenty-Five-Year Follow-up of a Randomized Trial Comparing Radical Mastectomy, Total Mastectomy, and Total Mastectomy Followed by Irradiation

    Authors: Bernard Fisher, Jong‐Hyeon Jeong, Stewart Anderson, John Bryant, Edwin R. Fisher, Norman Wolmark - New England Journal of Medicine 2002 cited by 1,386

  9. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.

    Authors: Bernard Fisher, John Bryant, Norman Wolmark, E.P. Mamounas, A Brown, Edwin R. Fisher, D. Lawrence Wickerham, Mirsada Begovič, Arthur P. DeCillis, A Robidoux, Richard G. Margolese, Anatolio B. Cruz, James L. Hoehn, Alan Lees, N V Dimitrov, Harry D. Bear - Journal of Clinical Oncology 1998 cited by 2,192

  10. Assessment of Cardiac Dysfunction in a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel, With or Without Trastuzumab As Adjuvant Therapy in Node-Positive, Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Cancer: NSABP B-31

    Authors: Elizabeth Tan-Chiu, Greg Yothers, Edward H. Romond, Charles E. Geyer, Michael S. Ewer, Deborah Keefe, Richard P. Shannon, Sandra M. Swain, Ann Brown, Louis Fehrenbacher, Victor G. Vogel, Thomas E. Seay, Priya Rastogi, Eleftherios P. Mamounas, Norman Wolmark, John Bryant - Journal of Clinical Oncology 2005 cited by 807

  11. Beyond an Updated Graded Prognostic Assessment (Breast GPA): A Prognostic Index and Trends in Treatment and Survival in Breast Cancer Brain Metastases From 1985 to Today

    Authors: Paul W. Sperduto, Shane Mesko, Jing Li, Daniel Cagney, Ayal A. Aizer, Nancy U. Lin, Eric Nesbit, Tim J. Kruser, Jason W. Chan, Steve Braunstein, Jessica Lee, John P. Kirkpatrick, Will Breen, Paul D. Brown, Diana D. Shi, Helen A. Shih, Hany Soliman, Arjun Sahgal, Ryan Shanley, William Sperduto, Emil Lou, Ashlyn S. Everett, Drexell H. Boggs, Laura Masucci, David Roberge, Jill Remick, Kristin A. Plichta, John M. Buatti, Supriya Jain, Laurie E. Gaspar, Cheng–Chia Wu, Tony J. C. Wang, John Bryant, Michael D. Chuong, James B. Yu, Veronica Chiang, Toshimichi Nakano, Hidefumi Aoyama, Minesh P. Mehta - International Journal of Radiation Oncology*Biology*Physics 2020 cited by 147

  12. Tamoxifen, Radiation Therapy, or Both for Prevention of Ipsilateral Breast Tumor Recurrence After Lumpectomy in Women With Invasive Breast Cancers of One Centimeter or Less

    Authors: Bernard Fisher, John Bryant, James J. Dignam, D. Lawrence Wickerham, Eleftherios P. Mamounas, Edwin R. Fisher, Richard G. Margolese, Lois Nesbitt, Soonmyung Paik, Thomas M. Pisansky, Norman Wolmark - Journal of Clinical Oncology 2002 cited by 696

  13. Paclitaxel After Doxorubicin Plus Cyclophosphamide As Adjuvant Chemotherapy for Node-Positive Breast Cancer: Results From NSABP B-28

    Authors: Eleftherios P. Mamounas, John Bryant, Barry C. Lembersky, Louis Fehrenbacher, Scot Sedlacek, Bernard Fisher, D. Lawrence Wickerham, Greg Yothers, Atilla Soran, Norman Wolmark - Journal of Clinical Oncology 2005 cited by 714

  14. Tumor escape from immune recognition: lethal recurrent melanoma in a patient associated with downregulation of the peptide transporter protein TAP-1 and loss of expression of the immunodominant MART-1/Melan-A antigen.

    Authors: Markus Maeurer, Susanne M. Gollin, D Martin, William Swaney, John Bryant, Chiara Castelli, Paul D. Robbins, Giorgio Parmiani, Walter J. Storkus, M T Lotze - Journal of Clinical Investigation 1996 cited by 286

  15. Which Pneumococcal Serogroups Cause the Most Invasive Disease: Implications for Conjugate Vaccine Formulation and Use, Part I

    Authors: William P. Hausdorff, John Bryant, Peter R. Paradiso, George R. Siber - Clinical Infectious Diseases 2000 cited by 872

  16. Estrogen/progesterone receptor and HER2 discordance between primary tumor and brain metastases in breast cancer and its effect on treatment and survival

    Authors: Paul W. Sperduto, Shane Mesko, Jing Li, Daniel Cagney, Ayal A. Aizer, Nancy U. Lin, Eric Nesbit, Tim J. Kruser, Jason W. Chan, Steve Braunstein, Jessica Lee, John P. Kirkpatrick, Will Breen, Paul D. Brown, Diana D. Shi, Helen A. Shih, Hany Soliman, Arjun Sahgal, Ryan Shanley, William Sperduto, Emil Lou, Ashlyn S. Everett, Drexell H. Boggs, Laura Masucci, David Roberge, Jill Remick, Kristin A. Plichta, John M. Buatti, Supriya Jain, Laurie E. Gaspar, Cheng–Chia Wu, Tony J. C. Wang, John Bryant, Michael D. Chuong, James B. Yu, Veronica Chiang, Toshimichi Nakano, Hidefumi Aoyama, Minesh P. Mehta - Neuro-Oncology 2020 cited by 77

  17. Weighing the Risks and Benefits of Tamoxifen Treatment for Preventing Breast Cancer

    Authors: Mitchell H. Gail, Joseph P. Costantino, John Bryant, Robert T. Croyle, Laurence S. Freedman, Kathy J. Helzlsouer, Victor G. Vogel - JNCI Journal of the National Cancer Institute 1999 cited by 671

  18. Pathobiology of preoperative chemotherapy

    Authors: Edwin R. Fisher, Jiping Wang, John Bryant, Bernard Fisher, Eletherios Mamounas, Norman Wolmark - Cancer 2002 cited by 413

  19. Treatment of lymph-node-negative, oestrogen-receptor-positive breast cancer: long-term findings from National Surgical Adjuvant Breast and Bowel Project randomised clinical trials

    Authors: Bernard Fisher, Jong‐Hyeon Jeong, John Bryant, Stewart Anderson, James J. Dignam, Edwin R. Fisher, Norman Wolmark - The Lancet 2004 cited by 360

  20. Incorporating Toxicity Considerations Into the Design of Two-Stage Phase II Clinical Trials

    Authors: John Bryant, Roger Day - Biometrics 1995 cited by 261

  21. American Society of Clinical Oncology Technology Assessment on the Use of Aromatase Inhibitors As Adjuvant Therapy for Postmenopausal Women With Hormone Receptor–Positive Breast Cancer: Status Report 2004

    Authors: Eric P. Winer, Clifford A. Hudis, Harold J. Burstein, Antonio C. Wolff, Kathleen I. Pritchard, James N. Ingle, Rowan T. Chlebowski, Richard D. Gelber, S.B. Edge, Julie R. Gralow, Melody Cobleigh, Eleftherios P. Mamounas, Lori J. Goldstein, Timothy J. Whelan, Trevor J. Powles, John Bryant, Cheryl Perkins, Judy Perotti, Susan Braun, Amy S. Langer, George P. Browman, Mark R. Somerfield - Journal of Clinical Oncology 2004 cited by 1,034

  22. Patterns of Locoregional Failure in Patients With Operable Breast Cancer Treated by Mastectomy and Adjuvant Chemotherapy With or Without Tamoxifen and Without Radiotherapy: Results From Five National Surgical Adjuvant Breast and Bowel Project Randomized Clinical Trials

    Authors: Alphonse G. Taghian, Jong‐Hyeon Jeong, Eleftherios P. Mamounas, Stewart Anderson, John Bryant, Melvin Deutsch, Norman Wolmark - Journal of Clinical Oncology 2004 cited by 381

  23. NSABP-32: Phase III, randomized trial comparing axillary resection with sentinal lymph node dissection: A description of the trial

    Authors: David N. Krag, Thomas B. Julian, Seth P. Harlow, Donald L. Weaver, Taka Ashikaga, John Bryant, Richard M. Single, Norman Wolmark - Annals of Surgical Oncology 2004 cited by 109

  24. Estrogen Receptor Status of Primary Breast Cancer Is Predictive of Estrogen Receptor Status of Contralateral Breast Cancer

    Authors: Sandra M. Swain, John Wilson, Eleftherios P. Mamounas, John Bryant, D. Lawrence Wickerham, Bernard Fisher, Soon Young Paik, Norman Wolmark - JNCI Journal of the National Cancer Institute 2004 cited by 105